References
- Babatin, M., Lee, S.S., Pollak, P.T. Amiodarone hepatotoxicity. (2008). Curr Vasc Pharmacol 6:228–236.
- Chan, A.L., Hsieh, H.J., Hsieh, Y.A., Lin, S.J. (2008). Fatal amiodarone-induced hepatotoxicity: a case report and literature review. Int J Clin Pharmacol Ther 46:96–101.
- Coban, S., Köklü, S., Sencer, H., Ekiz, F., Ormeci, N. (2007). Low dose amiodarone associated cirrhosis. J Gastroenterol Hepatol 22:140–141.
- Elizari, M.V., Martínez, J.M., Belziti, C., Ciruzzi, M., Pérez de la Hoz, R., Sinisi, A., et al. (2000). Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicéntricos en Argentina. Eur Heart J 21:198–205.
- Huang, X., Yang, Y., Zhu, J., Gao, X., Wang, G., Tan, H., et al. (2009). Clinical applications and acute hepatotoxicity of intravenous amiodarone. J Int Med Res 37:1928–1936.
- Ott, M.C., Khoor, A., Leventhal, J.P., Paterick, T.E., Burger, C.D. (2003). Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 123:646–651.
- Waldhauser, K.M., Török, M., Ha, H.R., Thomet, U., Konrad, D., Brecht, K., Follath, F., Krähenbühl, S. (2006). Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 319:1413–1423.